ReviewFrontiers in oncology2023

Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials.

Junjie Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.